InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Takeda Pharmaceutical Co Ltd, External Director. Insider active across 6 companies, notably Phathom Pharmaceuticals, Inc.. Aggregated, 31 disclosures have been recorded. Breakdown: 0 buy · 22 sells. Total volume traded: €33.1m. History available since 3 May 2021. The latest transaction was disclosed on 8 December 2025 (C). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Takeda Pharmaceutical Co Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
1,250,000 shares0Common StockSEC:0001395064-25-000172:0
6,724,000 shares@ US$1.95100.0% of flowCommon StockSEC:0001395064-25-000140:0
3,703,703 shares@ US$8.1081.7% of flowCommon StockSEC:0001395064-24-000008:0
5,883,500 shares0Common StockSEC:0001395064-22-000146:0
5,750,000 shares0Common StockSEC:0001395064-22-000121:0
7,359,304 shares0Common StockSEC:0001395064-22-000040:0
128,745 shares@ US$18.430.22% mcap45.6% of flowCommon StockSEC:0001395064-21-000248:0
12,517 shares@ US$18.470.021% mcap4.4% of flowCommon StockSEC:0001395064-21-000246:0
57,224 shares0Common StockSEC:0001395064-21-000238:0
228,696 shares0Common StockSEC:0001395064-21-000231:0
1,475,121 sharesCommon StockSEC:0001395064-21-000216:0
1,615,427 sharesCommon StockSEC:0001395064-21-000203:0
2,609 shares@ US$35.050.3% of flowCommon StockSEC:0001395064-21-000153:0
8,226 shares@ US$35.160.8% of flowCommon StockSEC:0001395064-21-000148:0
22,881 shares@ US$35.462.2% of flowCommon StockSEC:0001395064-21-000142:0
200 shares@ US$35.000.0% of flowCommon StockSEC:0001395064-21-000125:0
9,294 shares@ US$35.310.9% of flowCommon StockSEC:0001395064-21-000121:0
3,305 shares@ US$35.080.3% of flowCommon StockSEC:0001395064-21-000119:0
2,826 shares@ US$35.060.3% of flowCommon StockSEC:0001395064-21-000113:0
1,191 shares@ US$35.280.1% of flowCommon StockSEC:0001395064-21-000111:0
2,264 shares@ US$35.050.2% of flowCommon StockSEC:0001395064-21-000109:0
4,300 shares@ US$35.180.4% of flowCommon StockSEC:0001395064-21-000107:0
4,133 shares@ US$35.370.4% of flowCommon StockSEC:0001395064-21-000105:0
7,469 shares@ US$36.450.7% of flowCommon StockSEC:0001395064-21-000103:0
8,911 shares@ US$35.580.8% of flowCommon StockSEC:0001395064-21-000089:0
25 of 31 declarations
About Takeda Pharmaceutical Co Ltd
TAKEDA PHARMACEUTICAL CO LTD is an External Director associated with Phathom Pharmaceuticals, Inc., Day One Biopharmaceuticals, Inc., Ovid Therapeutics Inc., HilleVax, Inc., Xilio Therapeutics, Inc. and Theseus Pharmaceuticals, Inc. The declarant has 31 filings in total, and across the 31 sampled filings from 2021-05-05 to 2025-12-09, sell amounts total 33080776 EUR, with the dominant transaction nature listed as Cession.
